Functional consequences of mutations in the myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy.
暂无分享,去创建一个
[1] Frederick J. Schoen,et al. A Mouse Model of Familial Hypertrophic Cardiomyopathy , 1996, Science.
[2] Matthew J. Tyska,et al. R403Q and L908V mutant β-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level , 2004, Journal of Muscle Research & Cell Motility.
[3] Dm Warshaw,et al. THE IN VITRO MOTILITY ASSAY : A WINDOW INTO THE MYOSIN MOLECULAR MOTOR , 1996 .
[4] B. Hainque,et al. Familial hypertrophic cardiomyopathy: from mutations to functional defects. , 1998, Circulation research.
[5] W. Zhu,et al. Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy. , 1993, The Journal of clinical investigation.
[6] Roberto Dominguez,et al. Crystal Structure of a Vertebrate Smooth Muscle Myosin Motor Domain and Its Complex with the Essential Light Chain Visualization of the Pre–Power Stroke State , 1998, Cell.
[7] H M Holden,et al. X-ray structures of the myosin motor domain of Dictyostelium discoideum complexed with MgADP.BeFx and MgADP.AlF4-. , 1995, Biochemistry.
[8] D A Winkelmann,et al. Three-dimensional structure of myosin subfragment-1: a molecular motor. , 1993, Science.
[9] R. Roberts,et al. Accumulation and assembly of myosin in hypertrophic cardiomyopathy with the 403 Arg to Gln beta-myosin heavy chain mutation. , 1992, Circulation research.
[10] M. Bárány,et al. ATPase Activity of Myosin Correlated with Speed of Muscle Shortening , 1967, The Journal of general physiology.
[11] L. Leinwand,et al. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. , 1994, The Journal of biological chemistry.
[12] L. Leinwand,et al. Contractile protein mutations and heart disease. , 1996, Current opinion in cell biology.
[13] J. Sellers,et al. The in vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutation in hypertrophic cardiomyopathy , 1997, Journal of Muscle Research & Cell Motility.
[14] R A Milligan,et al. Structure of the actin-myosin complex and its implications for muscle contraction. , 1993, Science.
[15] H. Sugi,et al. Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication. , 1997, The Journal of clinical investigation.
[16] T. Hewett,et al. Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. , 2000, American journal of physiology. Heart and circulatory physiology.
[17] K. Trybus,et al. Smooth muscle myosin cross-bridge interactions modulate actin filament sliding velocity in vitro , 1990, The Journal of cell biology.
[18] H E Huxley,et al. The Mechanism of Muscular Contraction , 1965, Scientific American.
[19] L. Kunkel,et al. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy , 1989, Neuron.
[20] L. Fananapazir,et al. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. , 2000, Journal of molecular and cellular cardiology.
[21] A J Marian,et al. A transgenic rabbit model for human hypertrophic cardiomyopathy. , 1999, The Journal of clinical investigation.
[22] N. Alpert,et al. Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. , 1995, Circulation research.
[23] L. Leinwand,et al. Full-length rat alpha and beta cardiac myosin heavy chain sequences. Comparisons suggest a molecular basis for functional differences. , 1989, Journal of molecular biology.
[24] J. Seidman,et al. Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. , 2000, Circulation research.
[25] R. Cooke,et al. The mechanism of muscle contraction. , 1986, CRC critical reviews in biochemistry.
[26] M. Ikebe,et al. Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome. , 1996, The Journal of clinical investigation.
[27] L. Leinwand,et al. Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy. , 1998, Biophysical journal.
[28] M. Tyska,et al. Functional consequences of mutations in the smooth muscle myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy. , 2000, The Journal of biological chemistry.
[29] J. Seidman,et al. A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation , 1990, Cell.
[30] Niels Volkmann,et al. Evidence for cleft closure in actomyosin upon ADP release , 2000, Nature Structural Biology.
[31] D. Mann,et al. Expression of a Mutation Causing Hypertrophic Cardiomyopathy Disrupts Sarcomere Assembly in Adult Feline Cardiac Myocytes , 1995 .
[32] I. Rayment,et al. Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[33] K C Holmes,et al. Structural mechanism of muscle contraction. , 1999, Annual review of biochemistry.
[34] H. Bunn. Pathogenesis and treatment of sickle cell disease. , 1997, The New England journal of medicine.